Mark T Iwicki Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark T Iwicki.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark T Iwicki. Mark T Iwicki is EVP & Chief Commercial Officer in Sunovion Pharmaceuticals Inc. ($SEPR) and Chief Executive Officer in Kala Pharmaceuticals, Inc. ($KALA) and Director in Pulmatrix, Inc. ($PULM) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Akero Therapeutics, Inc. ($AKRO).

Latest Insider Trading Transactions of Mark T Iwicki

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AIMT, AKRO, KALA, PULM, SEPR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 01 2021	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	1.47	15,000	22,050	15,000
Feb 01 2021	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	1.47	15,000	22,050	15,000
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	D	17.11	15,398	263,460	0
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	D	19.90	11,432	227,497	0
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	D	32.79	7,500	245,925	0
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	D	18.26	17,500	319,550	0
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	D	15.40	19,755	304,227	0
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	D	6.29	87,368	549,545	0
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	D	3.02	52,421	158,311	0
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Sell	D	34.50	7,840	270,480	0	7.8 K to 0 (-100.00 %)
Oct 14 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Sell	U	34.50	39,567	1,365,062	0	39.6 K to 0 (-100.00 %)
Jun 29 2020	KALA	Kala Pharmaceutica ...	Iwicki Mark T	Chief Executive Off ...	Grant	A	0.00	49,560	0	49,560	0 to 49.6 K
Jun 02 2020	AKRO	Akero Therapeutics ...	Iwicki Mark T	Director	Option Exercise	A	25.20	13,000	327,600	13,000
May 29 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	A	17.11	15,398	263,460	15,398
May 29 2020	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Grant	A	0.00	7,840	0	47,407	39.6 K to 47.4 K (+19.81 %)
Apr 06 2020	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	1.28	10,000	12,800	10,000
Jan 13 2020	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	1.54	15,000	23,100	15,000
Jan 03 2020	KALA	Kala Pharmaceutica ...	Iwicki Mark T	Chief Executive Off ...	Option Exercise	A	3.84	365,000	1,401,600	365,000
May 28 2019	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	A	19.90	11,432	227,497	11,432
May 28 2019	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Grant	A	0.00	6,442	0	39,567	33.1 K to 39.6 K (+19.45 %)
May 20 2019	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	1.06	15,000	15,900	15,000
Jan 04 2019	KALA	Kala Pharmaceutica ...	Iwicki Mark T	Chief Executive Off ...	Option Exercise	A	5.19	460,000	2,387,400	460,000
Jun 06 2018	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	0.47	155,000	72,540	155,000
May 24 2018	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	A	32.79	7,500	245,925	7,500
May 24 2018	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Grant	A	0.00	3,750	0	33,125	29.4 K to 33.1 K (+12.77 %)
Apr 05 2018	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	P	0.75	307,000	230,250	307,000
Apr 05 2018	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	P	0.65	307,000	199,550	307,000
Apr 05 2018	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Buy	P	0.00	307,000	0	307,000	0 to 307 K
Feb 26 2018	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Buy	P	32.00	9,375	300,000	29,375	20 K to 29.4 K (+46.88 %)
Feb 09 2018	KALA	Kala Pharmaceutica ...	Iwicki Mark T	Chief Executive Off ...	Option Exercise	A	12.86	230,000	2,957,800	230,000
Jul 21 2017	KALA	Kala Pharmaceutica ...	Iwicki Mark T	Chief Executive Off ...	Option Exercise	A	15.00	78,632	1,179,480	78,632
May 30 2017	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	A	18.26	17,500	319,550	17,500
Mar 22 2017	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	2.78	4,400	12,232	4,400
May 27 2016	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Option Exercise	A	15.40	19,755	304,227	19,755
Dec 09 2015	PULM	Pulmatrix, Inc.	Iwicki Mark T	Director	Option Exercise	A	4.75	73,481	349,035	73,481
Aug 11 2015	AIMT	Aimmune Therapeuti ...	Iwicki Mark T	Director	Buy	P	16.00	20,000	320,000	20,000	0 to 20 K
Oct 22 2009	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Option Exercise	D	14.40	57,500	828,000	0
Oct 22 2009	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Option Exercise	D	21.26	42,165	896,428	0
Oct 22 2009	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Sell	D	23.00	122,334	2,813,682	0	122.3 K to 0 (-100.00 %)
Oct 19 2009	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Sell	U	23.00	27,666	636,318	122,334	150 K to 122.3 K (-18.44 %)
May 14 2009	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Option Exercise	A	14.40	57,500	828,000	57,500
May 14 2009	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Grant	A	14.40	35,000	504,000	150,000	115 K to 150 K (+30.43 %)
May 22 2008	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Option Exercise	A	21.26	42,165	896,428	42,165
May 22 2008	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Grant	A	21.26	35,000	744,100	115,000	80 K to 115 K (+43.75 %)
Oct 22 2007	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Option Exercise	A	24.89	150,000	3,733,500	150,000
Oct 22 2007	SEPR	Sunovion Pharmaceu ...	Iwicki Mark T	EVP & Chief Commerc ...	Grant	A	24.89	80,000	1,991,200	80,000	0 to 80 K

Page: 1